Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MERCK, SANDOZ PRESS RELEASES ON BRISTOL CARE STUDY DRAW SCRUTINY FROM FDA AD DIVISION; RPR TAXOTERE NEWS RELEASES DEEMED "NOT OBJECTIVE" BY AGENCY

Executive Summary

Merck and Sandoz have been cited by FDA's Division of Drug Marketing, Advertising & Communications for issuing press releases attempting to piggyback on clinical trial results for Bristol-Myers Squibb's Pravachol.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029221

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel